Completed OBSERVATIONAL NCT02818868

Impact of Apixaban on Clinical Outcome of the Patients With Large Vessel Occlusion or Stenosis Trial (ALVO)

Sponsor: Hyogo Medical University

Interventions apixisaban

Updated 10 times since 2017 Last updated: Dec 20, 2021 Started: Jul 31, 2016 Primary completion: Feb 28, 2018 Completion: Feb 28, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02818868, this observational or N/A phase trial focuses on Ischemic Stroke and remains completed. Sponsored by Hyogo Medical University, it has been updated 10 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
May 2023 — Jul 2024 [monthly]

Completed
Feb 2022 — May 2023 [monthly]

Completed
Jan 2021 — Feb 2022 [monthly]

Completed

▶ Show 5 earlier versions

Sep 2019 — Jan 2021 [monthly]

Completed

Status: Unknown Status → Completed
Jun 2019 — Sep 2019 [monthly]

Unknown Status

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Jun 2019 [monthly]

Not Yet Recruiting
Apr 2018 — Jun 2018 [monthly]

Not Yet Recruiting

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Not Yet Recruiting NA

First recorded

Jul 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hyogo Medical University

Data source: Hyogo Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nishinomiya, Japan